314 related articles for article (PubMed ID: 30381081)
1. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
4. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
[TBL] [Abstract][Full Text] [Related]
6. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
Hardy KK; Embry L; Kairalla JA; Helian S; Devidas M; Armstrong D; Hunger S; Carroll WL; Larsen E; Raetz EA; Loh ML; Yang W; Relling MV; Noll RB; Winick N
J Clin Oncol; 2017 Aug; 35(23):2700-2707. PubMed ID: 28671857
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
10. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive outcome and white matter anisotropy in childhood acute lymphoblastic leukemia survivors treated with different protocols.
ElAlfy M; Ragab I; Azab I; Amin S; Abdel-Maguid M
Pediatr Hematol Oncol; 2014 Mar; 31(2):194-204. PubMed ID: 24498883
[TBL] [Abstract][Full Text] [Related]
12. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
Montour-Proulx I; Kuehn SM; Keene DL; Barrowman NJ; Hsu E; Matzinger MA; Dunlap H; Halton JM
J Child Neurol; 2005 Feb; 20(2):129-33. PubMed ID: 15794179
[TBL] [Abstract][Full Text] [Related]
13. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
[TBL] [Abstract][Full Text] [Related]
14. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
[TBL] [Abstract][Full Text] [Related]
15. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
[TBL] [Abstract][Full Text] [Related]
16. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
[TBL] [Abstract][Full Text] [Related]
17. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.
Waber DP; Tarbell NJ; Kahn CM; Gelber RD; Sallan SE
J Clin Oncol; 1992 May; 10(5):810-7. PubMed ID: 1569453
[TBL] [Abstract][Full Text] [Related]
18. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
Kunin-Batson A; Kadan-Lottick N; Neglia JP
Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
[TBL] [Abstract][Full Text] [Related]
19. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only.
Lofstad GE; Reinfjell T; Hestad K; Diseth TH
Acta Paediatr; 2009 Jan; 98(1):180-6. PubMed ID: 18826490
[TBL] [Abstract][Full Text] [Related]
20. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer.
Jankovic M; Brouwers P; Valsecchi MG; Van Veldhuizen A; Huisman J; Kamphuis R; Kingma A; Mor W; Van Dongen-Melman J; Ferronato L
Lancet; 1994 Jul; 344(8917):224-7. PubMed ID: 7913156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
